Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$197.56
+1.31%
Mkt Cap $137.13B
Analyst Ratings
Buy
14
Hold
4
Sell
0
Price Target (52 analysts)
$230.89
Range $200.00 – $265.00
Implied Upside
+16.9%
Consensus $230.89 vs current $197.56